Poly Medicure Ltd - Stock Valuation and Financial Performance

BSE: 531768 | NSE: POLYMED | Medical Equipment/Supplies/Accessories | Small Cap

Poly Medicure Share Price

1,588.85 4.65 0.29%
as on 28-Mar'24 16:01

DeciZen - make an informed investing decision on Poly Medicure

Overall Rating
Bole Toh

1. Quality

2. Valuation

Overvalued

3. Price Trend

Semi Strong

Poly Medicure stock performance -

mw4me loader
P/E Ratio (SA):
63.89
Market Cap:
15,247.8 Cr.
52-wk low:
921
52-wk high:
1,727

Is Poly Medicure Ltd an attractive stock to invest in?

1. Is Poly Medicure Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Poly Medicure Ltd is a good quality company.

2. Is Poly Medicure Ltd undervalued or overvalued?

The key valuation ratios of Poly Medicure Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Poly Medicure Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Poly Medicure Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Poly Medicure:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Poly Medicure Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good

Value Creation

Value Creation Index Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
ROCE % 25.1%21.2%17.8%16.5%17.1%14.1%17.2%15.4%12.4%14%-
Value Creation
Index
0.80.50.30.20.20.00.20.1-0.10.0-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 3123743944405085876467478791,0681,240
Sales YoY Gr.-19.7%5.6%11.4%15.7%15.4%10.1%15.7%17.7%21.5%-
Adj EPS 4.5555.67.16.99.612.914.317.924.9
YoY Gr.-9%0.8%12.4%27.1%-3.1%39.4%34%10.7%25.6%-
BVPS (₹) 16.321.825.430.537.94348.699.4112.1128.4144.5
Adj Net
Profit
4043.74449.562.960.985124137172239
Cash Flow from Ops. 65.363.361.95575.5113127116126195-
Debt/CF from Ops. 11.21.31.81.71.31.51.10.90.7-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 14.6%16%18.2%21.5%
Adj EPS 16.5%20.3%23%25.6%
BVPS25.8%27.7%38.2%14.5%
Share Price 30.6% 48.9% 25% 69.8%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
Return on
Equity %
31.42621.220.120.817.12117.913.514.918.2
Op. Profit
Mgn %
25.522.621.921.423.922.825.128.224.325.326.9
Net Profit
Mgn %
12.811.711.211.312.410.413.216.515.616.119.3
Debt to
Equity
0.50.40.40.40.40.40.40.10.10.1-
Working Cap
Days
132136144146157159173182177173112
Cash Conv.
Cycle
5254677580807878899270

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 18.20%

Sales growth is growing at healthy rate in last 3 years 18.24%

Net Profit is growing at healthy rate in last 3 years 23.02%

Sales growth is good in last 4 quarters at 21.77%

No data to display

Latest Financials - Poly Medicure Ltd.

Standalone Consolidated
TTM EPS (₹) 24.9 25.9
TTM Sales (₹ Cr.) 1,240 1,305
BVPS (₹.) 144.5 146.1
Reserves (₹ Cr.) 1,339 1,354
P/BV 11.00 10.87
PE 63.89 61.31
From the Market
52 Week Low / High (₹) 921.00 / 1727.00
All Time Low / High (₹) 0.50 / 1727.00
Market Cap (₹ Cr.) 15,248
Equity (₹ Cr.) 48
Face Value (₹) 5
Industry PE 59.3

Management X-Ray of Poly Medicure:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Poly Medicure

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Sales3123743944395085876467478791,068
Operating Expenses 238289308345387453484537665802
Manufacturing Costs7896100113131143153162200243
Material Costs79103107110121152153197261300
Employee Cost 5060698194110127131150188
Other Costs 32303341414851475470
Operating Profit 74858694122134162210214266
Operating Profit Margin (%) 23.7%22.6%21.9%21.4%23.9%22.8%25.1%28.1%24.3%24.9%
Other Income 18814141619193936
Interest 91010811132010510
Depreciation 14182023283639465356
Exceptional Items 102000000000
Profit Before Tax 6284657696100122173195237
Tax 19231820263429444958
Profit After Tax 43614756706692130146179
PAT Margin (%) 13.8%16.3%12.0%12.8%13.8%11.3%14.3%17.3%16.6%16.8%
Adjusted EPS (₹)4.96.95.46.48.07.510.513.515.218.7
Dividend Payout Ratio (%)20%18%28%39%25%27%19%19%16%16%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23

Equity and Liabilities

Shareholders Fund 1441922242693343794299531,0751,232
Share Capital 22222244444444484848
Reserves 1221702022252903353859051,0271,184
Minority Interest0000000000
Debt495861761061271559181112
Long Term Debt394031487991111603112
Short Term Debt101830282735443150101
Trade Payables29383041435060567878
Others Liabilities 6166616371105128131100173
Total Liabilities 2823543764495556617721,2311,3341,596

Fixed Assets

Gross Block194252288333417461550655764965
Accumulated Depreciation7391111133161192226270317367
Net Fixed Assets120161177200256269324385447597
CWIP 20101420181925214378
Investments 6666184658385384176
Inventories405441586974101109150183
Trade Receivables46598195112124120149191221
Cash Equivalents 14202122205322278176
Others Assets384537476176122154110165
Total Assets 2823543764495556617721,2311,3341,596

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Cash Flow From Operating Activity 6563625575113127116126195
PBT 5265657696100122173195237
Adjustment 33412522384150453960
Changes in Working Capital -2-19-14-25-36-1-10-58-60-44
Tax Paid -18-23-14-18-23-27-36-44-47-58
Cash Flow From Investing Activity -58-57-30-54-87-104-106-434-89-187
Capex -58-48-31-55-81-45-104-93-150-237
Net Investments -1-9-1-2-8-62-7-3445748
Others 1123235342
Cash Flow From Financing Activity 6-9-31-114-10-22319-40-8
Net Proceeds from Shares 000000040000
Net Proceeds from Borrowing 0000000000
Interest Paid -8-8-8-7-9-12-9-8-4-8
Dividend Paid -5-10-27-13-5-21-420-24-24
Others 1810419292330-73-1224
Net Cash Flow 13-2103-1-11-20
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Ratios
ROE (%)33.836.3422.7522.8123.2818.5822.8518.7414.415.52
ROCE (%)38.5839.3726.1425.325.9622.9224.6421.6217.6819.34
Asset Turnover Ratio1.281.191.11.081.020.970.910.750.690.73
PAT to CFO Conversion(x)1.511.031.320.981.071.711.380.890.861.09
Working Capital Days
Receivable Days51516472747369657070
Inventory Days42454340454449515457
Payable Days1201191161171271121311089495

Poly Medicure Ltd Stock News

Poly Medicure Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Poly Medicure on 28-Mar-2024 16:01 is ₹1,588.9.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 28-Mar-2024 16:01 the market cap of Poly Medicure stood at ₹15,247.8.
The latest P/E ratio of Poly Medicure as of 28-Mar-2024 16:01 is 63.89.
The latest P/B ratio of Poly Medicure as of 28-Mar-2024 16:01 is 11.00.
The 52-week high of Poly Medicure is ₹1,727 and the 52-week low is ₹921.0.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Poly Medicure is ₹1,240 ( Cr.) .

About Poly Medicure Ltd

Poly Medicure Ltd. was conceived and established by a group of engineers and technocrats dedicated to the idea of providing the benefits of modern healthcare to the mankind at affordable price. This unique philosophy has been the driving force behind the company since its inception in 1995. Today it has grown into one of the most dynamically versatile manufacturers of disposable healthcare products in the region with over 60 different products.

POLYMED manufactures its products using state of the art technology in ultra modern facilities covering over 300,000 square feet of manufacturing floor space with about 50,000 square feet of clean rooms of class 100,000 to class 1,000. A tool room with modern facilities & CNC machines supports the manufacturing processes. A high degree of automation and an effective process control helps in delivering consistent product quality.

To keep pace with the ever changing requirements of the market, POLYMED has a fully staffed and highly equipped R & D section to design and develop new and innovative products. Using the latest CAD/CAM technology, the new product development is fast and improvements, based on market response and customer feedback, are made with ease. Assuring world class products at affordable prices is the hall mark of POLYMED

Product range of the company:

The company manufactures different products related to :

  • Infusion Therapy
  • Central Venous Access Catheters
  • Anaesthesia
  • Urology
  • Gastroenterology
  • Blood Management
  • Surgery & Wound Drainage
  • Dialysis
  • Others

Achievements/ recognition:

  • QMS (Quality Management System) accredited by SGS
  • ISO 9001:2000
  • ISO-13485:2003
  • CE mark from DNV
  • US FDA 510k approved  
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.